These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 37016465)
1. A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables. Xu F; Peng L; Feng J; Zhu X; Pan Y; Hu Y; Gao X; Ma Y; He Y Cancer Imaging; 2023 Apr; 23(1):34. PubMed ID: 37016465 [TBL] [Abstract][Full Text] [Related]
2. Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis. Minamitake A; Murakami R; Shiraishi S; Yoshida R; Sakata J; Hirosue A; Kawahara K; Yamana K; Nakayama H; Kitajima M; Sakamoto F Oral Radiol; 2022 Jul; 38(3):438-442. PubMed ID: 35088222 [TBL] [Abstract][Full Text] [Related]
3. Accurate preoperative staging with [ Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the harmonized maximum standardized uptake value of 18F-FDG-PET/CT in patients with resectable oral tongue squamous cell carcinoma: a multicenter study. Kaida H; Kitajima K; Sekine T; Ito K; Daisaki H; Kimura T; Sato MP; Enomoto A; Otsuki N; Ishii K Dentomaxillofac Radiol; 2023 Oct; 52(7):20230083. PubMed ID: 37494001 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma. Matsubara R; Kawano S; Chikui T; Kiyosue T; Goto Y; Hirano M; Jinno T; Nagata T; Oobu K; Abe K; Nakamura S Acad Radiol; 2012 Jun; 19(6):708-17. PubMed ID: 22484437 [TBL] [Abstract][Full Text] [Related]
6. Preoperative Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737 [TBL] [Abstract][Full Text] [Related]
7. Utility of SUV Lim RS; Ramdave S; Beech P; Billah B; Karim MN; Smith JA; Safdar A; Sigston E Cancer Imaging; 2016 Nov; 16(1):39. PubMed ID: 27821180 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Song Y; Tian Y; Lu X; Chen G; Lv X Med Phys; 2024 Jul; 51(7):4907-4921. PubMed ID: 38252704 [TBL] [Abstract][Full Text] [Related]
9. Prediction of cervical metastasis and survival in cN0 oral cavity cancer using tumour Bae MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY J Cancer Res Clin Oncol; 2020 Dec; 146(12):3341-3348. PubMed ID: 32642973 [TBL] [Abstract][Full Text] [Related]
14. FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0. Stack BC; Duan F; Subramaniam RM; Romanoff J; Sicks JD; Bartel T; Chen C; Lowe VJ Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1230-1239. PubMed ID: 33231504 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma. Lee SJ; Choi JY; Lee HJ; Baek CH; Son YI; Hyun SH; Moon SH; Kim BT Korean J Radiol; 2012; 13(6):752-9. PubMed ID: 23118574 [TBL] [Abstract][Full Text] [Related]
16. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105 [TBL] [Abstract][Full Text] [Related]
17. [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT. Suenaga Y; Kitajima K; Kanda T; Otsuki N; Nibu K; Sasaki R; Itoh T; Sugimura K Jpn J Radiol; 2016 Mar; 34(3):203-10. PubMed ID: 26670594 [TBL] [Abstract][Full Text] [Related]
18. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603 [TBL] [Abstract][Full Text] [Related]
19. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791 [TBL] [Abstract][Full Text] [Related]
20. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers. Shah H; Wang Y; Cheng SC; Gunasti L; Chen YH; Lako A; Guenette J; Rodig S; Jo VY; Uppaluri R; Haddad R; Schoenfeld JD; Jacene HA JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):268-276. PubMed ID: 35050348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]